Log in to save to my catalogue

Propofol versus midazolam sedation in patients with cardiogenic shock - an observational propensity-...

Propofol versus midazolam sedation in patients with cardiogenic shock - an observational propensity-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2661481942

Propofol versus midazolam sedation in patients with cardiogenic shock - an observational propensity-matched study

About this item

Full title

Propofol versus midazolam sedation in patients with cardiogenic shock - an observational propensity-matched study

Publisher

United States: Elsevier Inc

Journal title

Journal of critical care, 2022-10, Vol.71, p.154051-154051, Article 154051

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Benzodiazepines are recommended as first line sedative agent in ventilated cardiogenic shock patients, although data regarding the optimal sedation strategy are sparse. The aim of this study was to investigate the hemodynamic effects of propofol versus midazolam sedation in our cardiogenic shock registry.
Mechanically ventilated patients sufferi...

Alternative Titles

Full title

Propofol versus midazolam sedation in patients with cardiogenic shock - an observational propensity-matched study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2661481942

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2661481942

Other Identifiers

ISSN

0883-9441

E-ISSN

1557-8615

DOI

10.1016/j.jcrc.2022.154051

How to access this item